Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T14:35:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 30, 2025, while a date for March 25, 2025, has been removed.
    Difference
    1.0%
    Check dated 2025-04-09T09:40:42.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    63 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T21:08:37.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T10:08:51.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The website has been updated to version v2.14.2, with the previous status of 'Active, not recruiting' removed.
    Difference
    1%
    Check dated 2025-02-03T08:52:39.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:32:05.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.